Loading market dashboard
MedX Health Corp
MDXHFHealthcareOTCCA
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 15, 2026, when it announced application for an extension of time within which to effect further closings of the Non-brokered Private Placement to accredited investors of Series IV Convertible Loan Notes (“Series IV Notes”) originally announced in its Press Release dated February 2, 2026, and the First Closing which was announced in.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated March 16, 2026, when it announced application for an extension of time within which to effect further closings of the Non-brokered Private Placement to accredited investors of Series IV Convertible Loan Notes (“Series IV Notes”) originally announced in its Press Release dated February 2, 2026, and the First Closing which was announced in.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 27, 2026, when it announced the Initial Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 2, 2026, it has made application to the TSX Venture Exchange for an extension of 30 days to April 15, 2026, within which to effect further closings on this Private.
